Assignee

Biosplice Therapeutics, Inc.

Patents = 17

Trademarks = 7

Forward Citations = 30

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

19 inventors (with patents filed for the assignee):

Biosplice Therapeutics, Inc. is a biotechnology company focused on developing innovative RNA splice-modulating therapies. Our cutting-edge research aims to address unmet medical needs in various disease areas, including oncology and rare genetic disorders. With a team of experienced scientists and industry experts, we are committed to advancing new treatment options for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com